Atkinson COVID-19 grants could inform policy decisions

Cornell University
1-May-2020 10:20 PM EDT, by Cornell University

Newswise — ITHACA, N.Y. – The Cornell Atkinson Center for Sustainability has announced its first two Rapid Response Fund grants since calling for emergency proposals in early April. The faculty research grants are aimed at helping find solutions to issues created by the COVID-19 pandemic.

The funded research projects could yield new tools and reports that may help policymakers make better decisions – during pandemics or other health crises.

One project aims to produce a mathematical model that allows government officials to manage human mobility during a pandemic. It will be led by Samitha Samaranayake, assistant professor in civil and environmental engineering.

The other will examine real-time consumer surveys on economic expectations during COVID-19 social distancing, which could lead to more efficient reopening of regional economies. It will be led by Lars Vilhuber, executive director of the Labor Dynamics Institute at the ILR School.

“The response to our special research call has indicated a desire by Cornell faculty to help contribute solutions to the current public health and economic crisis,” said David Lodge, the Francis J. DiSalvo Director of Cornell Atkinson. “Our hope is that early support from our Rapid Response Fund can lead to immediate analysis and insight that helps to build interdisciplinary research in the area of One Health and pay dividends for future public health planning and response.”

The pandemic has raised questions about the links between mobility and infectious disease transmission, said Samaranayake, who has expertise in modeling and transportation networks.

Samaranayake will partner with Benedetto Piccoli, professor of mathematics and vice chancellor for research at Rutgers University - Camden; and Daniel Work, associate professor of engineering and computer science at Vanderbilt University.

“We are trying to develop new epidemiological models that explicitly account for how people move around at a local scale,” Samaranayake said, suggesting that such models can support disease containment and mitigation, and back economic recovery measures that minimize travel disruption while limiting disease spread.

“The primary benefit to society is the development of improved models and tools for municipal and state officials, to better grasp the spread of infectious disease by incorporating travel dynamics into epidemiological models,” Samaranayake said.

Vilhuber’s research will include weekly rapid-response surveys in the U.S. and Canada to capture critical indicators of consumer behavior in response to social distancing.

“Current surveys capture the change in business and consumer behavior only at monthly or quarterly frequencies – and rarely with geographic detail,” said Vilhuber, who is partnering with Fabian Lange, professor of labor and economics at McGill University, Montreal.

Vilhuber and Lange will capture and examine metrics involving consumer uncertainty and expectation related to social distancing and the closure of nonessential businesses, as actual policy responses to the crisis evolve. They will collect responses weekly through the middle of summer, expecting to draw real-time inferences about consumers’ and business’s states of mind.

Cornell Atkinson Rapid Response Fund proposals are being accepted through June 30.

Filters close

Showing results

110 of 4573
Released: 15-Jan-2021 5:40 PM EST
Research Links Social Isolation to COVID-19 Protocol Resistance
Humboldt State University

As health officials continue to implore the public to wear masks and practice social distancing, recent research by Humboldt State University Psychology Professor Amber Gaffney provides key insights into connections between social isolation, conspiratorial thinking, and resistance to COVID-19 protocols.

Newswise: Rapid blood test identifies COVID-19 patients at high risk of severe disease
Released: 15-Jan-2021 5:35 PM EST
Rapid blood test identifies COVID-19 patients at high risk of severe disease
Washington University in St. Louis

Scientists at Washington University School of Medicine in St. Louis have shown that a relatively simple and rapid blood test can predict which patients with COVID-19 are at highest risk of severe complications or death. The blood test measures levels of mitochondrial DNA, which normally resides inside the energy factories of cells. Mitochondrial DNA spilling out of cells and into the bloodstream is a sign that a particular type of violent cell death is taking place in the body.

Released: 15-Jan-2021 2:55 PM EST
COVID-19 deaths really are different. But best practices for ICU care should still apply, studies suggest.
Michigan Medicine - University of Michigan

COVID-19 deaths are indeed different from other lung failure deaths, according to two recent studies, with 56% of COVID-19 patients dying primarily from the lung damage caused by the virus, compared with 22% of those whose lungs fail due to other causes. But, the researchers conclude, the kind of care needed to help sustain people through the worst cases of all forms of lung failure is highly similar, and just needs to be fine-tuned.

Released: 15-Jan-2021 2:50 PM EST
45% of adults over 65 lack online medical accounts that could help them sign up for COVID-19 vaccinations
Michigan Medicine - University of Michigan

As the vaccination of older adults against COVID-19 begins across the country, new poll data suggests that many of them don’t yet have access to the “patient portal” online systems that could make it much easier for them to schedule a vaccination appointment. In all, 45% of adults aged 65 to 80 had not set up an account with their health provider’s portal system.

Released: 15-Jan-2021 1:30 PM EST
New England Journal of Medicine publishes COVID-19 treatment trial results
University of Texas at San Antonio

A clinical trial involving COVID-19 patients hospitalized at UT Health San Antonio and University Health, among roughly 100 sites globally, found that a combination of the drugs baricitinib and remdesivir reduced time to recovery, according to results published Dec. 11 in the New England Journal of Medicine.

Released: 15-Jan-2021 12:40 PM EST
DNA test can quickly identify pneumonia in patients with severe COVID-19, aiding faster treatment
University of Cambridge

Researchers have developed a DNA test to quickly identify secondary infections in COVID-19 patients, who have double the risk of developing pneumonia while on ventilation than non-COVID-19 patients.

Released: 15-Jan-2021 12:30 PM EST
Fight CRC To Present Research Findings on The Impact of COVID-19 on the Colorectal Cancer Community at 2021 GI ASCO
Fight Colorectal Cancer

Fight Colorectal Cancer presents abstract at Gastrointestinal Cancer Symposium highlighting the need to address the barriers and opportunities for care within the colorectal cancer community during the COVID-19 pandemic

Released: 15-Jan-2021 12:25 PM EST
Technion to Award Honorary Doctorate to Pfizer CEO Dr. Albert Bourla
American Technion Society

Israel's Technion will award an honorary doctorate to Pfizer CEO and Chairman Dr. Albert Bourla, for leading the development of the novel vaccine against SARS-CoV-2, the virus that causes COVID-19. The honorary doctorate will be conferred at the Technion Board of Governors meeting in November 2021.

Released: 15-Jan-2021 11:30 AM EST
UW researchers develop tool to equitably distribute limited vaccines
University of Wisconsin-Madison

Researchers at the University of Wisconsin School of Medicine and Public Health and UW Health have developed a tool that incorporates a person’s age and socioeconomic status to prioritize vaccine distribution among people who otherwise share similar risks due to their jobs.

Showing results

110 of 4573